Paul Tudor Jones's MEDP Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 8,699 shares of Medpace Holdings, Inc. (MEDP) worth $4.18 M, representing 0.01% of the portfolio. First purchased in 2016-Q3, this long-term strategic position has been held for 26 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in MEDP, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 66,232 shares. Largest reduction occurred in Q1 2026, reducing 80,543 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Medpace Holdings (MEDP) Holding Value Over Time
Track share changes against reported price movement
Quarterly Medpace Holdings (MEDP) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -80,543 | Reduce 90.25% | 8,699 | $480.19 |
| Q4 2025 | +66,232 | Add 287.84% | 89,242 | $561.65 |
| Q3 2025 | -804 | Reduce 3.38% | 23,010 | $514.16 |
| Q2 2025 | +23,814 | New Buy | 23,814 | $313.86 |
| Q2 2024 | -1,143 | Sold Out | 0 | $0.00 |
| Q1 2024 | -5,883 | Reduce 83.73% | 1,143 | $404.15 |
| Q4 2023 | -22,138 | Reduce 75.91% | 7,026 | $306.53 |
| Q3 2023 | -1,301 | Reduce 4.27% | 29,164 | $242.13 |
| Q2 2023 | +10,245 | Add 50.67% | 30,465 | $240.17 |
| Q1 2023 | +15,269 | Add 308.40% | 20,220 | $0.19 |
| Q4 2022 | +4,951 | New Buy | 4,951 | $0.21 |
| Q1 2022 | -3,022 | Sold Out | 0 | $0.00 |
| Q4 2021 | +3,022 | New Buy | 3,022 | $217.74 |
| Q4 2020 | -4,814 | Sold Out | 0 | $0.00 |
| Q3 2020 | -15,082 | Reduce 75.80% | 4,814 | $111.76 |
| Q2 2020 | +19,896 | New Buy | 19,896 | $93.03 |
| Q4 2018 | -26,458 | Sold Out | 0 | $0.00 |
| Q3 2018 | +19,718 | Add 292.55% | 26,458 | $59.91 |
| Q2 2018 | +6,740 | New Buy | 6,740 | $43.03 |
| Q1 2018 | -6,934 | Sold Out | 0 | $0.00 |
| Q4 2017 | -3,711 | Reduce 34.86% | 6,934 | $36.20 |
| Q3 2017 | -1,778 | Reduce 14.31% | 10,645 | $31.94 |
| Q2 2017 | +5,559 | Add 80.99% | 12,423 | $28.98 |
| Q1 2017 | +967 | Add 16.40% | 6,864 | $29.87 |
| Q4 2016 | -3,998 | Reduce 40.40% | 5,897 | $36.12 |
| Q3 2016 | +9,895 | New Buy | 9,895 | $29.81 |
Paul Tudor Jones's Medpace Holdings Investment FAQs
Paul Tudor Jones first purchased Medpace Holdings, Inc. (MEDP) in Q3 2016, acquiring 9,895 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Medpace Holdings, Inc. (MEDP) for 26 quarters since Q3 2016.
Paul Tudor Jones's largest addition to Medpace Holdings, Inc. (MEDP) was in Q4 2025, adding 89,242 shares worth $50.12 M.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 8,699 shares of Medpace Holdings, Inc. (MEDP), valued at approximately $4.18 M.
As of the Q1 2026 filing, Medpace Holdings, Inc. (MEDP) represents approximately 0.01% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Medpace Holdings, Inc. (MEDP) was 89,242 shares, as reported at the end of Q4 2025.